Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials.
about
Reasons for ineligibility in phase 1 and 2A HIV vaccine clinical trials at Kenya AIDS vaccine initiative (KAVI), Kenya.CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.Reference values for clinical laboratory parameters in young adults in Maputo, Mozambique.Experiences on recruitment and retention of volunteers in the first HIV vaccine trial in Dar es Salam, Tanzania - the phase I/II HIVIS 03 trialEffect of seasonal variation on adult clinical laboratory parameters in Rwanda, Zambia, and Uganda: implications for HIV biomedical prevention trials.Indeterminate and discrepant rapid HIV test results in couples' HIV testing and counselling centres in AfricaSex and Urbanicity Contribute to Variation in Lymphocyte Distribution across Ugandan PopulationsIncidental diagnosis in healthy clinical trial subjectsImmunohaematological reference values for HIV-negative healthy adults in BotswanaThe microbiologic safety of umbilical cord blood transfusion for children with severe anemia in Mombasa, Kenya.Immunohaematological reference values for HIV-negative healthy adults in Botswana.Reference intervals for hematology test parameters from apparently healthy individuals in southwest Ethiopia
P2860
Q30399174-3D900452-1ED8-4BE4-A9A8-03237A2205F9Q33406262-5EF24D2C-ED2C-460E-AAA3-5D44C055240EQ33610296-258FF6F1-09FD-4D78-99BD-DAD57FD0120CQ33645168-15B6CE06-2D28-4BF1-ADB5-94B14D1C411CQ34041851-B6D350D4-0252-4DFD-9B31-82E826A871C6Q34915821-90B36B91-306C-4A33-B8D0-F02C6CAEC98FQ35885093-7FAC6BEE-C5A7-4AB5-BF11-D27335133A5EQ36301976-C6E92A07-3639-45C2-BCB0-64469035D947Q36929552-EAB4D83F-6468-4602-B624-DECF044F98C4Q43046980-B51D09AF-4E71-4D66-8483-5009B48B5255Q50073436-2D552BAE-BE0D-4000-A6C3-253866E77B49Q58599654-F7CE2706-0040-4BF3-A13F-780416C1E389
P2860
Baseline morbidity in 2,990 adult African volunteers recruited to characterize laboratory reference intervals for future HIV vaccine clinical trials.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Baseline morbidity in 2,990 ad ...... e HIV vaccine clinical trials.
@ast
Baseline morbidity in 2,990 ad ...... e HIV vaccine clinical trials.
@en
type
label
Baseline morbidity in 2,990 ad ...... e HIV vaccine clinical trials.
@ast
Baseline morbidity in 2,990 ad ...... e HIV vaccine clinical trials.
@en
prefLabel
Baseline morbidity in 2,990 ad ...... e HIV vaccine clinical trials.
@ast
Baseline morbidity in 2,990 ad ...... e HIV vaccine clinical trials.
@en
P2093
P2860
P50
P1433
P1476
Baseline morbidity in 2,990 ad ...... e HIV vaccine clinical trials.
@en
P2093
Andrea von Lieven
Bashir Farah
Gwynn Stevens
Helen Thomson
Jill Gilmour
Joseph Mulenga
Josephine Birungi
Lisa Stoll-Johnson
Marietta Krebs
P2860
P356
10.1371/JOURNAL.PONE.0002043
P407
P577
2008-04-30T00:00:00Z